InvestorsHub Logo
Followers 4
Posts 105
Boards Moderated 0
Alias Born 03/05/2021

Re: None

Wednesday, 01/25/2023 9:43:01 AM

Wednesday, January 25, 2023 9:43:01 AM

Post# of 463738
Mercola - FDA Accelerated Approval for Risky Lecanemab, reliance on drugs to reduce amyloid beta may be misguided.
FDA Approves Risky Lecanemab
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News